BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37102996)

  • 21. Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice.
    Hong P; Li FX; Gu RN; Fang YY; Lai LY; Wang YW; Tao T; Xu SY; You ZJ; Zhang HF
    Neural Plast; 2018; 2018():9163521. PubMed ID: 29853850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Narirutin Attenuates Cerebral Ischemia-Reperfusion Injury by Suppressing the TXNIP/NLRP3 Pathway.
    Luo L; Wang S; Liu W; Zhang Z; Zhao M; Liu A
    Neurochem Res; 2024 Mar; 49(3):692-705. PubMed ID: 38047987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective Effects of Vinpocetine Against Ischemia-Reperfusion Injury Via Inhibiting NLRP3 Inflammasome Signaling Pathway.
    Hou B; Li D; Wang D; Jiang C; Wang G; Wang D; Yan G; Guo X; Zhao L; Wan Z; Fan C; Cao W; Ren H
    Neuroscience; 2023 Aug; 526():74-84. PubMed ID: 37290685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkin-Dependent Mitophagy is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats.
    He Q; Li Z; Meng C; Wu J; Zhao Y; Zhao J
    Cells; 2019 Aug; 8(8):. PubMed ID: 31416289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ChemR23 signaling ameliorates brain injury via inhibiting NLRP3 inflammasome-mediated neuronal pyroptosis in ischemic stroke.
    Liu L; Zhang J; Lu K; Zhang Y; Xu X; Deng J; Zhang X; Zhang H; Zhao Y; Wang X
    J Transl Med; 2024 Jan; 22(1):23. PubMed ID: 38178174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-κB/NLRP3 Pathway in Ischemic Stroke.
    Li F; Xu D; Hou K; Gou X; Lv N; Fang W; Li Y
    J Neuroimmune Pharmacol; 2021 Dec; 16(4):835-853. PubMed ID: 33512659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of perilipin 2 attenuates cerebral ischemia/reperfusion injury by blocking NLRP3 inflammasome activation both in vivo and in vitro.
    Liu XY; Li QS; Yang WH; Qiu Y; Zhang FF; Mei XH; Yuan QW; Sui RB
    In Vitro Cell Dev Biol Anim; 2023 Mar; 59(3):204-213. PubMed ID: 37010675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anfibatide alleviates inflammation and apoptosis via inhibiting NF-kappaB/NLRP3 axis in ischemic stroke.
    Li R; Si M; Jia HY; Ma Z; Li XW; Li XY; Dai XR; Gong P; Luo SY
    Eur J Pharmacol; 2022 Jul; 926():175032. PubMed ID: 35584710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TSPO knockdown attenuates OGD/R-induced neuroinflammation and neural apoptosis by decreasing NLRP3 inflammasome activity through PPARγ pathway.
    Wang K; Wang G; Zhou B
    Brain Res Bull; 2022 Sep; 187():1-10. PubMed ID: 35738501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome.
    Wang X; Li R; Wang X; Fu Q; Ma S
    Neurosci Lett; 2015 Jul; 600():182-7. PubMed ID: 26071904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice.
    Franke M; Bieber M; Kraft P; Weber ANR; Stoll G; Schuhmann MK
    Brain Behav Immun; 2021 Feb; 92():223-233. PubMed ID: 33307174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling.
    Zhao J; Piao X; Wu Y; Liang S; Han F; Liang Q; Shao S; Zhao D
    Biomed Pharmacother; 2020 Jul; 127():110151. PubMed ID: 32559840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury.
    Hou Y; Wang Y; He Q; Li L; Xie H; Zhao Y; Zhao J
    Behav Brain Res; 2018 Jan; 336():32-39. PubMed ID: 28851669
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Xiao Q; Kang Z; Liu C; Tang B
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):300. PubMed ID: 36472098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astilbin protects against cerebral ischaemia/reperfusion injury by inhibiting cellular apoptosis and ROS-NLRP3 inflammasome axis activation.
    Li Y; Wang R; Xue L; Yang Y; Zhi F
    Int Immunopharmacol; 2020 Jul; 84():106571. PubMed ID: 32413740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. XingNaoJing injections protect against cerebral ischemia/reperfusion injury and alleviate blood-brain barrier disruption in rats, through an underlying mechanism of NLRP3 inflammasomes suppression.
    Qu XY; Zhang YM; Tao LN; Gao H; Zhai JH; Sun JM; Song YQ; Zhang SX
    Chin J Nat Med; 2019 Jul; 17(7):498-505. PubMed ID: 31514981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats.
    Yu C; He Q; Zheng J; Li LY; Hou YH; Song FZ
    Int Immunopharmacol; 2017 Apr; 45():74-78. PubMed ID: 28189971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of heat shock protein family A member 8 attenuates spinal cord ischemia-reperfusion injury via astrocyte NF-κB/NLRP3 inflammasome pathway : HSPA8 inhibition protects spinal ischemia-reperfusion injury.
    Mi J; Yang Y; Yao H; Huan Z; Xu C; Ren Z; Li W; Tang Y; Fu R; Ge X
    J Neuroinflammation; 2021 Aug; 18(1):170. PubMed ID: 34362408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIM59 suppresses the brain ischaemia/reperfusion injury and pyroptosis of microglial through mediating the ubiquitination of NLRP3.
    Zhang L; Li G; Li Y
    Sci Rep; 2024 Jan; 14(1):2511. PubMed ID: 38291200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal administration of β-1, 3-galactosyltransferase 2 confers neuroprotection against ischemic stroke by likely inhibiting oxidative stress and NLRP3 inflammasome activation.
    Guo X; Zhang Y; Liu C; Ren L; Gao S; Bi J; Liang J; Wang P
    FASEB J; 2022 Oct; 36(10):e22542. PubMed ID: 36094000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.